Activation isn't a feature we bolted on. It's a property of how the plan is made.
The behavioral evidence is unambiguous: people don't activate when they're told what to do; they activate when they're part of the planning. Wubs is built around that finding rather than decorated with it. The act of co-designing a care plan is itself the intervention — which is why the same loop works for a patient in any condition.
A plan a patient ignores is worth nothing. And patients ignore plans handed to them.
The 2015–2020 industry's answer to forward-looking care was the care pathway: branching, templated plans authored centrally by clinical committees. The category's own published evidence is the indictment. The peer-reviewed activation rate for a major vendor's post-discharge digital care plan was 27.4% — roughly one invited patient in four ever turned it on. The reason isn't a missing feature. It's the design stance. A pathway is written for a generic patient by people who never met you, then asks you to conform to it. That works about as well as the numbers say.
Co-design isn't how we deliver the plan. It's the active ingredient.
Planning is the precise behavior you most want a patient to perform: to deliberate, own, and commit to their own care. Doing the planning for them skips the one step that actually activates them. So Wubs splits the job the way it should always have been split — clinicians provide the clinical clarity they alone are qualified to provide and have already documented; Wubs co-designs the rest of the plan with the patient.
What that co-design does, mechanistically:
- It supports autonomy in the self-determination-theory sense — the patient is the author, not the recipient. The plan is theirs because they built it.
- It surfaces capability and opportunity gaps while they're cheap to fix — before the plan is set, not after it has already failed in the wild.
- It forces an honest early accounting of what the patient can and can't actually do, given their real life.
- It deletes the quiet shame of "not following doctor's orders" that drives patients to disengage and hide — there's nothing to defy when it's your own plan.
And it happens on the patient's own timeline — before a visit, after a visit, and across the long stretches in between — not in a fifteen-minute window a few times a year from a standing start.
We don't just cite COM-B. We make it part of the same machine as the clinical work.
The organizing framework is COM-B (Michie, van Stralen & West, 2011): any Behavior is the product of Capability, Opportunity, and Motivation, with a behavioral diagnosis preceding any intervention. This is the reason "just remind them" underperforms: a reminder addresses only the forgetting component, while most non-adherence is rooted elsewhere — and even self-reported "forgetting" is frequently a proxy for low perceived need, cost, or competing priority (Gadkari & McHorney, 2012). For every goal, Wubs runs that diagnosis per person and per behavior — which of capability, opportunity, or motivation is the live barrier here — and then does the thing that makes it more than a survey: it models those human factors as directed data-capture items inside the very same context envelope that holds the missing lab and the pending visit note.
COM-B: a behavioral diagnosis precedes any intervention.
Can they?
Does the patient have the knowledge and skill? The gap in understanding a taper schedule is a tracked, fillable item, not an assumption.
The chance?
Does their environment, time, and social context permit it? The night shift that makes the morning dose impossible is a fact the plan must bend around.
The drive?
Do their beliefs, identity, emotions, and habits pull toward or against it? The quiet belief that the medication is optional; the identity of "someone who's never been an exerciser." These are load-bearing.
These are facts that will never exist in any data aggregator. They're not in Health Connect, not in MyChart, not in a general chatbot's history. This is precisely why plans authored for you fail — they have no slot for any of it.
Clinical, wearable, and motivational data — in concert, not in silos.
To the best of our knowledge, Wubs is the only product that cross-analyzes wearable data, clinical data, and motivational data as three inputs to one reasoning step rather than three apps in three silos. The watch knows you slept badly; the chart knows you're on a new medication; only Wubs puts those next to your stated dread of the side effect and reasons across all three to shape what it says next. For a behavioral scientist, this is the point: motivation isn't a separate "engagement" layer — it sits in the same reasoning step as the physiology.
We measure progress, not time-on-app.
A great deal of behavioral design in consumer apps is, honestly, dark-pattern engineering: manufactured urgency, streaks, variable rewards that capture attention detached from any real outcome. Wubs treats that as a failure mode, not a feature. Completion copy names progress, not a manufactured deadline. The system has no incentive to keep you in the app — its only job is to move the clinical metric the goal is defined by. Activation, here, means activation toward the patient's own care, not toward our retention dashboard.
Standing on the established science.
- Michie, van Stralen & West (2011). The behaviour change wheel. Implementation Science 6:42. — behavior as Capability × Opportunity × Motivation, with a behavioral diagnosis before any intervention.
- Presseau et al. (2019). AACTT framework for specifying behavior — Action, Actor, Context, Target, Time.
- Ng et al. (2012). Self-Determination Theory applied to health contexts: a meta-analysis. Perspectives on Psychological Science 7(4). — autonomous motivation persists; externally-pressured behavior decays. The empirical case for co-design over compliance.
- Sheldon & Elliot (1999). The self-concordance model. JPSP 76(3).
- Horne et al. (2013). The Necessity–Concerns Framework: a meta-analytic review. PLOS ONE 8(12). — adherence tracks necessity beliefs weighed against concerns, out-predicting clinical and sociodemographic factors.
- Gadkari & McHorney (2012). Unintentional non-adherence: how unintentional is it really? BMC Health Services Research 12:98.
- Greene, Hibbard et al. (2015). When patient activation levels change, health outcomes and costs change, too. Health Affairs 34(3). — higher activation is associated with better outcomes and lower cost. (Associative, not a causal guarantee — we cite it as it is.)